James McLaughlin
Direttore/Membro del Consiglio presso Avantus Holdings LLC
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Andrew Maner | M | - |
Avantus Holdings LLC
 Avantus Holdings LLC Financial ConglomeratesFinance Avantus Holdings LLC operates as a development stage company. The company is headquartered in Radnor, PA. | - |
| Walter P. Maner | M | - |
Avantus Holdings LLC
Avantus Holdings LLC Financial ConglomeratesFinance Avantus Holdings LLC operates as a development stage company. The company is headquartered in Radnor, PA. | - |
| James Ashton | M | - |
Avantus Holdings LLC
Avantus Holdings LLC Financial ConglomeratesFinance Avantus Holdings LLC operates as a development stage company. The company is headquartered in Radnor, PA. | - |
| Jason Rhodes | M | 54 |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | 8 anni |
| Lee A. Garber | M | - |
Avantus Holdings LLC
Avantus Holdings LLC Financial ConglomeratesFinance Avantus Holdings LLC operates as a development stage company. The company is headquartered in Radnor, PA. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Johanna Seddon | M | - |
Gemini Therapeutics Sub, Inc.
Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | - |
| Paul Barlow | M | - |
Gemini Therapeutics Sub, Inc.
Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | - |
| Andrew Herbert | M | - |
Gemini Therapeutics Sub, Inc.
Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 8 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- James McLaughlin
- Contatti personali
